未登录

Y

Yiping Qu

Xi'an Jiaotong University First Affiliated Hospital

H指数:20

被引数:1,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NTRK2 promotes malignant progression and paclitaxel resistance of lung adenocarcinoma through targeting MYC/ABCF1 axis

NTRK2通过靶向MYC/ABCF1轴促进肺腺癌的恶性进展和紫杉醇耐药性。

Translational Oncology

IF4.1

2026-01-060

OAAI

Stereotactic radiotherapy for nAMD: areas for improvement

立体定向放射治疗用于nAMD：需要改进的方面

IF0

2025-07-030

PRE

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial

IF88.5

2024-05-010

PRE

Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib

IF2.9

2024-04-021

PRE

High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade

IF3.4

2024-03-262

OAAI

Boosting the proton conduction in a magnetic dysprosium-organic framework by introducing conjugate NH4+-NH3 pairs

CHINESE CHEMICAL LETTERS

IF8.9

2024-01-0110

OAAI

Octahedral lanthanide clusters containing a central PO43- anion: structural, luminescent, magnetic and relaxometric properties

DALTON TRANSACTIONS

IF3.3

2023-01-017

PRE

Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers

瞬时受体电位melastatin相关基因7 (TRPM7) 启动子甲基化预测Luminal a乳腺癌患者预后较好

IF3.4

2022-09-055

OAAI

Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype

CELL DEATH & DISEASE

IF9.6

2021-08-032

OAAI

Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017

IF3.7

2019-09-2349

OAAI

Liu, Zhidai; Yu, Chaowen; Li, Qingge; Cai, Ren; Qu, Yiping; Wang, Weipeng; Wang, Jie; Feng, Jinwen; Zhu, Wenbin; Ou, Mingcai; Huang, Weitong; Tang, Deguo; Guo, Wei; Liu, Fangjie; Chen, Yanhua; Fu, Lifang; Zhou, Yanxia; Lv, Wenqiong; Zhang, Hang; Zhang, Juan; Wang, Ming; Yang, Jing; Wan, Kexing; Miao, Jingkun; Yuan, Zhaojian; Liu, Hao; He, Xiaoyan; Li, Wenjie; Chen, Wengao; Ye, Lixin; Chen, Yajun; Huang, Shuodan; Liu, Haiping; Ding, Hongxiang; Gan, Xinhui; Wang, Shuyuan; Qiang, Rong; Gong, Minhong; Teng, Ping; Wang, Hua; Zhou, Muping; Wei, Hongwei; Liu, Xiangju; Tang, Kai; Ma, Yahong; Wu, Hongliang; Shu, Xiaoli; Chen, Yizhen; Zhuang, Danyan; Li, Hui; Liu, Zhi; Liu, Xiulian; Chen, Yao; Zhu, Lidan; Zhu, Xiaoyan; Mo, Caihong; Tang, Hua; Yin, Feng; Shao, Zhibing; Zhang, Penghui; Peng, Bin; Lu, Qing; Wang, Zhiguo; Zou, Lin

Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy

治疗性肽自组装成刺激响应性簇状纳米杂化物用于癌症靶向治疗

ADVANCED FUNCTIONAL MATERIALS

IF19

2019-01-2366

OAAI

Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy

将丝鹿蛋白转化为自组装的可生物降解纳米平台，用于多靶向癌症治疗

IF16

2018-10-1644

PREAI

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

CHEMISTRY OF MATERIALS

IF7

2018-09-2140

OAAI

SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis

IF7.3

2018-08-0949

PREAI

Activated ERK: An Emerging Player in miRNA Downregulation

TRENDS IN CANCER

IF17.5

2017-03-018

PREAI

c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis

IF13.3

2017-01-0136

OAAI

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer

CELL DEATH & DISEASE

IF9.6

2016-10-2748

OAAI

TERT promoter mutations predict worse survival in laryngeal cancer patients

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2014-01-2744

OAAI

Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2013-12-0536

PREAI

Gene methylation in gastric cancer

CLINICA CHIMICA ACTA

IF2.9

2013-09-01351

OAAI